Warts - Moles - Skin Tags

Manufacturer
Newton Laboratories, Inc.
Effective date
2011-06-01
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:05:10

Label at a glance#

ProductWarts - Moles - Skin Tags
Active ingredientAntimony Trisulfide, Bryonia Alba Root, Oyster Shell Calcium Carbonate, Crude, Causticum, Solanum Dulcamara Top, Graphite, Lycopodium Clavatum Spore, Mercuric Sulfide, Sodium Carbonate, Nitric Acid, Strychnos Nux-vomica Seed, Toxicodendron Pubescens Leaf, Juniperus Sabina Leafy Twig, Sepia Officinalis Juice, Silicon Dioxide, Delphinium Staphisagria Seed, Sulfur, Thuja Occidentalis Leafy Twig, Taraxacum Officinale
Label structure10 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

INDICATIONS & USAGE SECTION

Warts - Moles - Skin Tags  Formulated for various types of skin conditions such as warts (including genital), moles, keloids, molluscum and skin tags.

DOSAGE & ADMINISTRATION SECTION

DOSAGE & ADMINISTRATION SECTION

Directions: ORAL USE ONLY - SHAKE WELL.   Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) one to four times daily or as directed by a healthcare professional.  Under age 2, crush or dissolve pellets in purified water.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Antimon. crud. 20x, Bryonia 20x, Calc.carb. 20x, Causticum 20x, Dulcamara 20x, Graphites 20x, Lycopodium 20x, Merc. sulph. rub. 20x, Nat. carb. 20x, Nitricum ac. 20x, Nux vom. 20x, Rhus toxicodendron 20x, Sabina 20x, Sepia 20x, Silicea 20x, Staphysag. 20x, Sulphur 20x, Thuja occ. 20x, Taraxacum 8x, Thuja occ. 8x, Taraxacum 3x, Thuja occ. 3x.

PURPOSE SECTION

ABUSE SECTION

Formulated for various types of skin conditions such as warts (including genital), moles, keloids, molluscum and skin tags.

INACTIVE INGREDIENT SECTION

Inactive Ingredients:  Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net  Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions?  1.800.448.7256 

WARNINGS SECTION

Warning:  Do not use if tamper - evident seal is broken or missing.  Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.  Keep out of reach of children.  

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package label
package label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55714-4533-12020-01-31C16284748780-19d75b9d0-d294-f424-e053-dadaa90a57ceWarts - Moles - Skin Tags
55714-4533-22020-01-31C16284748780-19d75b9d0-d294-f424-e053-dadaa90a57ceWarts - Moles - Skin Tags

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55714-4533-1Warts - Moles - Skin Tags28.35 g in 1 BOTTLE, GLASSPELLET28.351
55714-4533-2Warts - Moles - Skin Tags56.7 g in 1 BOTTLE, GLASSPELLET56.71

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55714-4533WARTS - MOLES - SKIN TAGS (ANTIMON. CRUD., BRYONIA, CALC.CARB., CAUSTICUM, DULCAMARA, GRAPHITES, LYCOPODIUM, MERC. SULPH. RUB., NAT. CARB., NITRICUM AC., NUX VOM., RHUS TOXICODENDRON, SABINA, SEPIA, SILICEA, STAPHYSAG., SULPHUR, THUJA OCC.,TARAXACUM) PELLET [NEWTON LABORATORIES, INC.]1Legacy NDC, 2 package rows20131107_5465a1ad-e29f-21a7-1f51-fb3bdb481f20.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Antimony TrisulfideACTIVE INGREDIENTF79059A38U1
Bryonia Alba RootACTIVE INGREDIENTT7J046YI2B1
CausticumACTIVE INGREDIENTDD5FO1WKFU1
Delphinium Staphisagria SeedACTIVE INGREDIENT00543AP1JV1
GraphiteACTIVE INGREDIENT4QQN74LH4O1
Juniperus Sabina Leafy TwigACTIVE INGREDIENTZ5BEX9K2G11
Lycopodium Clavatum SporeACTIVE INGREDIENTC88X29Y4791
Mercuric SulfideACTIVE INGREDIENTZI0T668SF11
Nitric AcidACTIVE INGREDIENT411VRN1TV41
Oyster Shell Calcium Carbonate, CrudeACTIVE INGREDIENT2E32821G6I1
Sepia Officinalis JuiceACTIVE INGREDIENTQDL83WN8C21
Silicon DioxideACTIVE INGREDIENTETJ7Z6XBU41
Sodium CarbonateACTIVE INGREDIENT45P3261C7T1
Solanum Dulcamara TopACTIVE INGREDIENTKPS1B1162N1
Strychnos Nux-vomica SeedACTIVE INGREDIENT269XH139191
SulfurACTIVE INGREDIENT70FD1KFU701
Taraxacum OfficinaleACTIVE INGREDIENT39981FM3751
Thuja Occidentalis Leafy TwigACTIVE INGREDIENT1NT28V93971
Toxicodendron Pubescens LeafACTIVE INGREDIENT6IO182RP7A1
Antimony TrisulfideACTIVE MOIETYF79059A38U1
Bryonia Alba RootACTIVE MOIETYT7J046YI2B1
Carbonate IonACTIVE MOIETY7UJQ5OPE7D1
CausticumACTIVE MOIETYDD5FO1WKFU1
Delphinium Staphisagria SeedACTIVE MOIETY00543AP1JV1
GraphiteACTIVE MOIETY4QQN74LH4O1
Juniperus Sabina Leafy TwigACTIVE MOIETYZ5BEX9K2G11
Lycopodium Clavatum SporeACTIVE MOIETYC88X29Y4791
Mercuric CationACTIVE MOIETYED30FJ8Y421
Nitric AcidACTIVE MOIETY411VRN1TV41
Oyster Shell Calcium Carbonate, CrudeACTIVE MOIETY2E32821G6I1
Sepia Officinalis JuiceACTIVE MOIETYQDL83WN8C21
Silicon DioxideACTIVE MOIETYETJ7Z6XBU41
Solanum Dulcamara TopACTIVE MOIETYKPS1B1162N1
Strychnos Nux-vomica SeedACTIVE MOIETY269XH139191
SulfurACTIVE MOIETY70FD1KFU701
Taraxacum OfficinaleACTIVE MOIETY39981FM3751
Thuja Occidentalis Leafy TwigACTIVE MOIETY1NT28V93971
Toxicodendron Pubescens LeafACTIVE MOIETY6IO182RP7A1
SucroseINACTIVE INGREDIENTC151H8M5541

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55714-453355714-4533-1, 55714-4533-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SucroseSUCROSEC151H8M554TABLET / BUCCAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, CHEWABLE / ORAL7258 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUPPOSITORY / RECTALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SOLUTION / ORAL42596 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SUSPENSION / ORAL31885 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, EXTENDED RELEASE / ORAL619 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION/ DROPS / ORAL3750 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SYRUP / ORAL46400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, DELAYED RELEASE / ORAL955 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE / ORAL3568 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / SUBLINGUAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS900 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TROCHE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SOLUTION / ORAL70000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS9.4 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, EXTENDED RELEASE / ORAL284.54 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION / ORAL48209 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, DELAYED RELEASE / ORAL295.33 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, COATED, EXTENDED RELEASE / ORAL86 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TROCHE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS2000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION / SUBCUTANEOUS47.75 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554PASTILLE / ORAL426 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL18790 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CONCENTRATE / ORAL4800 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER / ORAL27768 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER, FOR SOLUTION / ORAL38666 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTABLE, LIPOSOMAL / INTRAVENOUS7560 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LIQUID / ORAL37500 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LOZENGE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554POWDER, FOR SUSPENSION / ORAL40017 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, EMULSION / INTRAVENOUS970 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554LOZENGE / TRANSMUCOSAL1255 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS308 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554WAFER / ORAL155.2 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS1 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554ELIXIR / ORAL18000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SUSPENSION, EXTENDED RELEASE / ORAL5400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, FILM COATED, EXTENDED RELEASE / ORAL119.12 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, COATED / ORAL516.42 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION / INTRAVENOUS1950 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554SOLUTION / RECTAL35.42 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554DROPS / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554INJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554CAPSULE, COATED PELLETS / ORAL59.8 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET, FILM COATED / ORAL145 mgExact identifier — unii candidate
48 equally ranked IID candidates
SucroseSUCROSEC151H8M554TABLET / ORAL4249 mgExact identifier — unii candidate
48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
af04301f-424e-b8ea-810b-1569d3e1d05a5465a1ad-e29f-21a7-1f51-fb3bdb481f202011-06-01WarningsExact identifier
spl id: af04301f-424e-b8ea-810b-1569d3e1d05a
spl set id: 5465a1ad-e29f-21a7-1f51-fb3bdb481f20

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.